 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|---|
|
   |
| CBD Biotechnology Inc. will focus on research, development and distribution of health products, including hemp-derived cannabidiol (“CBD”) products, as well as hemp-based food and beverage products. |
|
 Hot Stock to Watch |
Company: ChineseInvestors.com, Inc. (OTCQB: CIIX)
|
Last:
Price: 1.03
Change (%): + 0.00 (0.00)
Volume: 5,874 |
 |
ChineseInvestors.com, Inc. Launches CBD Biotechnology Inc. in British Columbia, Canada
SAN GABRIEL, California, June 14, 2017 /PRNewswire/ - ChineseInvestors.com, Inc. (OTCQB: CIIX) (“CIIX” or the “Company”), the premier financial information website for Chinese-speaking investors, today announces that it has incorporated CBD Biotechnology Inc. in British Columbia, Canada. CBD Biotechnology Inc. will focus on research, development and distribution of health products, including hemp-derived cannabidiol (“CBD”) products, as well as hemp-based food and beverage products.
In April 2017, fulfilling a campaign pledge, Prime Minister Justin Trudeau introduced legislation to legalize the recreational use of marijuana in Canada by the middle of 2018. Canada will become the second country to completely legalize marijuana as a consumer product. The law will require purchasers to be at least 18 years old, and it will limit the amount they can carry at any one time to 30 grams. While the federal government will license and regulate growers, each of Canada’s provinces will need to decide exactly how the drug will be distributed and sold within its boundaries.
“I am delighted about the incorporation of CBD Biotechnology Inc.,” says Warren Wang, founder and CEO of CIIX. “CBD Biotechnology Inc. is strategically located in British Columbia, Canada, known to be a cannabis friendly province. The British Columbia cannabis industry produces 40 percent of all Canadian cannabis, making cannabis among the most valuable cash crops in the province. While CIIX has been laying the groundwork to enter the legal cannabis market for some time, the complete legalization of cannabis in Canada provides another great opportunity for CIIX to enter the market.”
“The incorporation of CBD Biotechnology Inc. is a promising step forward towards CIIX’s goals to enter the medical marijuana industry. Through its expansion into Canada, CIIX aims generate significant revenues through sales of CBD-based health products, while helping the nearly one million Chinese in Canada to improve their overall health,” concludes Wang.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
